Forkhead BioTherapeutics Competitors and Similar CompaniesClear all
Forkhead BioTherapeutics's competitors and similar companies include Camurus, Melinta Therapeutics, Sosei Heptares and Travere Therapeutics.
 Forkhead BioTherapeutics Forkhead BioTherapeutics is a biotech company that develops transformative therapies. |  Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. |  Melinta Therapeutics Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
|  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 1991 | Founding Date 2000 | Founding Date 1990 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB | Locations Morristown, US HQ New Haven, US | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations San Diego, US HQ Dublin, IE |
Employees | Employees 1 | Employees 265 | Employees 1712% increase | Employees 387 | Employees 46293% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.4 b | Valuation ($) N/A | Valuation ($) 697 m | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr2.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods kr138.7m (FY, 2025) | Cost of goods N/A | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $10.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit kr2.1b (FY, 2025) | Gross profit N/A | Gross profit ¥24b (FY, 2025) | Gross profit $480.4m (FY, 2025) |
Net income | Net income N/A | Net income kr735.6m (FY, 2025) | Net income N/A | Net income (¥12.5b) (FY, 2025) | Net income ($25.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 519.2m | Total funding raised $ 65m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
Camurus
HQ
Lund, SE
Employees
265
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View companyMelinta Therapeutics
HQ
Morristown, US
Employees
171↑ 2% increase
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
View company
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View company